Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Journal of Cancer - Australia
doi 10.7150/jca.18014
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ivyspring International Publisher

Related search

Nuclear-Enriched Abundant Transcript 1 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

Disseminated Tumour Cells as a Prognostic Biomarker in Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

N-Cadherin, a Novel Prognostic Biomarker, Drives Malignant Progression of Colorectal Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

Apolipoprotein C1 (APOC1) as a Novel Diagnostic and Prognostic Biomarker for Lung Cancer: A Marker Phase I Trial

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2014English

Plasma microRNA Profiles: Identification of miR-1229-3p as a Novel Chemoresistant and Prognostic Biomarker in Gastric Cancer

Scientific Reports
Multidisciplinary
2020English

Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

Biomarker mRNAs as Prognostic Tools for Lymph Node Analysis in Colorectal Cancer

Biomarkers in Medicine
BiochemistryDrug DiscoveryClinical Biochemistry
2019English

LncRNA as a Diagnostic and Prognostic Biomarker in Bladder Cancer: A Systematic Review and Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2018English

Finding a New Prognostic Biomarker for Metastatic Colorectal Cancer

Journal of the Korean Society of Coloproctology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy